Back to Avoro Capital Advisors LLC

OCUL
Showing 8 of 9 quarters

Position history for Avoro Capital Advisors LLC's holdings in OCULAR THERAPEUTIX INC

Avoro Capital Advisors LLC holds 12.3M shares of OCUL (OCULAR THERAPEUTIX INC), worth $104.3M as of 2026-Q1. The position was increased (+14.3% shares). OCUL represents 1.0% of Avoro Capital Advisors LLC's portfolio.

Current Value

$104.3M

Current Shares

12.3M

Total Value Change

+$49.2M

Total Shares Change

+4.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
12.3M
+14.3%
$104.3M1.0%$10.76
55
2025-Q4
Increased
10.8M
+5.2%
$130.8M1.3%$12.20
51
2025-Q3
Increased
10.3M
+38.5%
$119.8M1.5%$12.53
63
2025-Q2
Decreased
7.4M
-8.2%
$68.7M1.2%$9.22
0
2025-Q1
Unchanged
8.1M
0.0%
$59.1M0.9%$7.58
0
2024-Q4
Unchanged
8.1M
0.0%
$68.8M1.0%$8.35
0
2024-Q3
Unchanged
8.1M
0.0%
$70.1M1.0%$8.68
0
2024-Q2
Increased
8.1M
+12.7%
$55.1M0.7%$6.84
48

Other major holders of OCUL: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used